WHO underlines poverty link to aggressive cervical cancer
This article was originally published in Clinica
The need for cheaper methods of delivering mass cervical cancer screening in developing countries was stressed last month by the World Health Organisation (WHO). Currently used cytological methods are simply too costly and thus beyond the purse of many in need of diagnosis and treatment.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.